HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher N Sozda Selected Research

5-HT1A Serotonin Receptor

7/2012Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.
2/2007Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher N Sozda Research Topics

Disease

4Traumatic Brain Injuries (Traumatic Brain Injury)
07/2012 - 02/2007

Drug/Important Bio-Agent (IBA)

3Serotonin (5 Hydroxytryptamine)IBA
07/2012 - 11/2010
2Buspirone (Buspar)FDA LinkGeneric
07/2012 - 07/2012
25-HT1A Serotonin ReceptorIBA
07/2012 - 02/2007
28-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
11/2010 - 02/2007